| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |